Tirzepatide (commonly known as Mounjaro or Zepbound) a newer option that targets both GLP-1 and GIP receptors, often leading to even greater weight loss compared to semaglutide
[PUBMED Abstract] Fizazi K, Herrmann K, Krause BJ, et al.: Health-related quality of life and pain outcomes with [177Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION): a multicentre, open-label, randomised, phase 3 trial
Our all-encompassing care approach means we manage the insurance, prior authorization, and persistent support aspects, empowering you to pursue and achieve your health goals with semaglutide efficiently in Victoria
Endocrinology 158: 17011714, 2017
There's a rare but possible risk of Thyroid C-cell Tumors in people with MTC or MEN 2 history
However, another review recommends not taking more than 70 mg per day to prevent a buildup of toxins